LENZ
Financials
- Market Capitalization 157.4 M
- Employee 152
- Founded 2013
- CEO N/A
- Website www.lenz-tx.com
- Headquarter Delaware, United States
- FIGI BBG00XDH4NZ2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3774 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 4.44 USD | +6.99% | +5.71% | +13.85% | +149.44% | 160.86 M USD | ||
| 3787 |  HUMA Humacyte, Inc. - Common Stock | 0.71 USD | +2.90% | -8.97% | -34.26% | -71.26% | 157.63 M USD | ||
| 3796 |  ADCT ADC Therapeutics SA Common Shares | 1.22 USD | -2.40% | -12.86% | +12.96% | -63.58% | 155.17 M USD | ||
| 3798 |  YDES YD Bio Limited - Ordinary Shares | 2.19 USD | +1.86% | +10.61% | -32.82% | -72.63% | 155.03 M USD |
Frequently asked questions about LENZ Therapeutics, Inc. - Common Stock
What is the LENZ Therapeutics, Inc. - Common Stock stock price today?
The current price of LENZ Therapeutics, Inc. - Common Stock (LENZ) is 5.02. Over the past 24 hours, the stock has changed by -4.02%. Follow the LENZ chart for real-time price dynamics.
What is the stock ticker of LENZ Therapeutics, Inc. - Common Stock?
LENZ Therapeutics, Inc. - Common Stock trades under the ticker LENZ. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is LENZ Therapeutics, Inc. - Common Stock stock going up?
LENZ has changed by -16.61% over the last week, -27.25% over the last month, and -84.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was LENZ Therapeutics, Inc. - Common Stock net income for the last quarter?
LENZ Therapeutics, Inc. - Common Stock reported net income of -41.49 M for the last quarter. The previous quarter showed -35.9 M, which means net income changed by -15.58%.
How many employees does LENZ Therapeutics, Inc. - Common Stock have?
As of the latest available data, LENZ Therapeutics, Inc. - Common Stock has 152 employees. Workforce size can provide additional context about the company's scale and operations.
What is LENZ Therapeutics, Inc. - Common Stock EBITDA?
LENZ Therapeutics, Inc. - Common Stock EBITDA is -44.02 M, and its EBITDA margin is -2 315.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy LENZ Therapeutics, Inc. - Common Stock stock?
You can buy LENZ Therapeutics, Inc. - Common Stock (LENZ) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in LENZ Therapeutics, Inc. - Common Stock stock?
Investing in LENZ Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LENZ chart and related analysis on metatrader.com as part of your research.